Morlat, P
117  Ergebnisse:
Personensuche X
?
1

The Impact of Immunosuppression on Chronic Kidney Disease i..:

Ryom L ; Lundgren J. D ; Reiss P...
info:eu-repo/semantics/altIdentifier/pmid/32640015.  , 2021
 
?
2

No need for secondary Pneumocystis jirovecii pneumonia prop..:

Atkinson A ; Miro J. M ; Mocroft A...
info:eu-repo/semantics/altIdentifier/pmid/34118121.  , 2021
 
?
3

The impact of immunosuppression on chronic kidney disease i..:

Ryom, L ; Lundgren, JD ; Reiss, P...
https://discovery.ucl.ac.uk/id/eprint/10105250/1/jiaa396.pdf.  , 2021
 
?
4

Withholding Primary Pneumocystis Pneumonia Prophylaxis in V..:

Atkinson A ; Zwahlen M ; Barger D...
info:eu-repo/semantics/altIdentifier/pmid/32448894.  , 2021
 
?
6

No need for secondary Pneumocystis jirovecii pneumonia prop..:

Atkinson, A ; Miro, JM ; Mocroft, A...
https://openaccess.sgul.ac.uk/id/eprint/113498/1/jia2.25726.pdf.  , 2021
 
?
7

No need for secondary Pneumocystis jirovecii pneumonia prop..:

Atkinson, A ; Miro, JM ; Mocroft, A...
https://discovery.ucl.ac.uk/id/eprint/10131277/1/Dunn_No_n.pdf.  , 2021
 
?
8

Withholding primary PcP prophylaxis in virologically suppre..:

Atkinson, A ; Zwahlen, M ; Barger, D...
https://discovery.ucl.ac.uk/id/eprint/10099241/1/Mocroft_Withholding%20primary%20PcP%20prophylaxis%20in%20virologically%20suppressed%20HIV%20patients_AAM.pdf.  , 2020
 
?
9

Withholding primary PcP prophylaxis in virologically suppre..:

Atkinson, A ; Zwahlen, M ; Barger, D...
info:eu-repo/semantics/altIdentifier/pmid/32448894.  , 2020
 
?
14

Body composition and adipokines changes after initial treat..:

Bernardino, JI ; Mocroft, A ; Wallet, C...
https://discovery.ucl.ac.uk/id/eprint/10067744/1/journal.pone.0209911.pdf.  , 2019
 
?
15

Use of contemporary protease inhibitors and risk of inciden..:

Ryom, L ; Lundgren, JD ; Reiss, P...
https://discovery.ucl.ac.uk/id/eprint/10081850/1/jiz369.pdf.  , 2019
 
1-15